BRIEF published on 04/11/2025 at 15:28, 7 months 23 days ago METRO AG Announces Delisting from Frankfurt Stock Exchange Frankfurt Stock Exchange Delisting METRO AG Prime Standard EP Global Commerce
PRESS RELEASE published on 04/11/2025 at 15:23, 7 months 23 days ago EQS-Adhoc: METRO AG: Delisting of METRO shares from Frankfurt Stock Exchange effective as of end of 16. April 2025 METRO AG announces delisting of shares from Frankfurt Stock Exchange effective April 16, 2025, following approval of revocation application Shares Frankfurt Stock Exchange Delisting METRO AG Approval
BRIEF published on 02/05/2025 at 18:14, 9 months 27 days ago METRO AG and EPGC Agree on Delisting of Shares Delisting Métro Shareholders Agreement EPGC SCore Strategy
PRESS RELEASE published on 02/05/2025 at 18:09, 9 months 27 days ago EQS-Adhoc: METRO AG and EPGC agree on delisting of METRO shares METRO AG and EPGC agree on delisting of METRO shares. Delisting offer includes a cash consideration of EUR 5.33 per share. Future plans for METRO announced Strategy Delisting METRO AG Cash Consideration EPGC
Published on 12/05/2025 at 02:35, 3 hours 41 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 16 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 11 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 16 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 45 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 25 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 50 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 1 minute ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 5 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 16 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 31 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 31 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 15 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
